Kidney Cancer Research Bureau
13 clinical trials · Sponsor
◉ Watch Kidney Cancer Research Bureau
| Record | Firm | Date |
|---|---|---|
| A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 (NCT07292168) | Kidney Cancer Research Bureau | 2025-12-02 |
| Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer (NCT05859477) | Kidney Cancer Research Bureau | 2022-06-05 |
| Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue (NCT06648902) | Kidney Cancer Research Bureau | 2022-02-01 |
| Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion. (NCT04749602) | Kidney Cancer Research Bureau | 2020-08-10 |
| Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment. (NCT04134182) | Kidney Cancer Research Bureau | 2019-10-16 |
Track Kidney Cancer Research Bureau automatically
Every clearance here is in the API, with alerts when new ones post.